PAIN TRIGGERS
Experiencing severe headaches when starting or taking Adderall IR.
Taking too high of an immediate dose causes counterproductive hyper-fixation (like on the phone).
SaaS· adults with ADHDPain 7.00/10WTP 5.0/10Market 7.0/10Validation 8.0Confidence 92%Oct 1, 2026
SplitDose: Precision Micro-Dosing and Symptom Tracker for ADHD Medication Transitions
Transitioning to Adderall IR 20mg delivers medication too fast, causing severe headaches, counterproductive phone hyper-fixation during peaks, and total crashes without supporting productivity.
analyticshealthmobile-appproductivityremote-teamssaasworkflow
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Switching to Adderall IR 20mg causes severe headaches, phone hyper-fixation during the peak, and a total lack of energy and motivation afterward, failing to support productivity.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Experiences on Adderall IR?
ADHD14
Experiences on Adderall IR?
ADHD14
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
adults with ADHDAdult A D H D Medication Switchers
Remote professionals and adults trying to optimize new stimulant dosages while balancing productivity and side effects like headaches and hyper-fixation.
Context
Find a medication dosage or management strategy for Adderall IR that eliminates headaches and phone hyper-fixation while improving work productivity and motivation.
Peer-sourcing advice and dosage management strategies from online communities like Reddit.
Splitting pills into multiple smaller doses throughout the day.
Current Workarounds
peer-sourcing dosage strategies from online communities like Reddit
manually splitting pills into smaller doses without precision tracking
trial-and-error adjustments without structured symptom logs
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Vyvanse took too long to kick in and caused sleep issues.
Adderall XR caused emotional numbness and depression.
Adderall IR 20mg all at once delivers too much medication too fast, causing severe side effects and crashes.
OPPORTUNITY & VALUE
Why Now
Repeated complaints regarding 20mg IR doses delivering medication too fast, causing severe headaches and phone hyper-fixation.
Value Proposition
Purpose-built specifically for tracking stimulant micro-dosing and titration side effects rather than generic habit tracking.
Product Direction
A dedicated digital companion and dosage-splitting calculator that helps users track micro-doses, monitor side effects like headaches or hyper-focus, and log productivity curves during medication transitions.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9/moIndividual proactive health tracking
Model
SaaS subscription
WILLINGNESS TO PAY
Users experience severe productivity loss and physical discomfort during medication switches; $9/mo is a low-friction investment for regaining work performance and avoiding debilitating crashes.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Optimize your ADHD medication titration and eliminate peak side effects.”
A dedicated digital companion and dosage-splitting calculator that helps users track micro-doses, monitor side effects like headaches or hyper-focus, and log productivity curves during medication transitions.
Core Features
Dosage-splitting schedule calculator and reminder log
Side-effect and focus-tracking check-ins (headaches, phone hyper-fixation, crash energy)
Exportable summary report for psychiatrists and medication check-ins
Weekly Roadmap
1
W1-W2
Core dosage schedule and pill-splitting calculator functional.
- •Build pill-splitting schedule configuration UI
- •Set up local data storage for custom split profiles
- •Implement basic dosing notification triggers
2
W3-W4
Symptom and focus-peak check-in flow operational.
- •Build quick-logging check-ins for headaches and hyper-fixation
- •Create daily energy and productivity curve visualization
- •Implement exportable PDF summary for doctor visits
3
W5
Subscription billing and private beta launch with 10 testers.
- •Integrate Stripe subscription checkout
- •Add medical disclaimer and safety guardrails
- •Recruit 10 ADHD community beta users
4
W6
Public launch in relevant online communities.
- •Launch on r/ADHD and related spaces
- •Collect initial feedback and bug fixes
- •Optimize onboarding flow based on drop-off data
Launch Strategy
Target ADHD support and medication communities on Reddit (r/ADHD, r/ADHD_anxiety) and X
RISKS & ASSUMPTIONS
Top Risks
Medical liability and regulatory scrutiny
Providing tools around pill splitting and dosing can border on medical advice, requiring strict disclaimers.
Short user lifetime value
Once users find a stable medication regimen with their doctor, they may churn out of the app.
Low daily tracking adherence
ADHD users struggle with consistent data logging, especially during low-energy crashes.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 2 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "analytics", "health", "mobile-app", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "SplitDose: Precision Micro-Dosing and Symptom Tracker for ADHD Medication Transitions" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for analytics?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.